VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 7 analysts with an average price target of $51.77. This is a potential upside of $27.24 (111.05%) from yesterday's end of day stock price of $24.53.

Vera Therapeutics's activity chart (see below) currently has 24 price targets and 44 ratings on display. The stock rating distribution of VERA is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.39% with an average time for these price targets to be met of 141 days.

Highest price target for VERA is $100, Lowest price target is $26, average price target is $60.86.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 07-May-2025. First documented stock forecast 08-Jun-2021.

Currently out of the existing stock ratings of VERA, 24 are a BUY (88.89%), 3 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$26

$1.81 (7.48%)

$38

4 months 4 days ago
(07-May-2025)

8/8 (100%)

$3.38 (14.94%)

169

Buy

$100

$75.81 (313.39%)

$107

4 months 4 days ago
(07-May-2025)

0/5 (0%)

$77.38 (342.09%)

Buy

$71

$46.81 (193.51%)

$75

6 months 7 days ago
(04-Mar-2025)

5/11 (45.45%)

$42.59 (149.91%)

271

Buy

$61

$36.81 (152.17%)

$64

6 months 15 days ago
(27-Feb-2025)

1/5 (20%)

$31.59 (107.41%)

163

Buy

$75

$50.81 (210.05%)

$20

10 months 14 days ago
(28-Oct-2024)

3/4 (75%)

$27.66 (58.43%)

252

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 141 days on average for the stock forecasts to be realized with a an average price target met ratio 63.39

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

LIISA BAYKO

Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Liisa Bayko works at EVERCORE and has 12 price targets and 12 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $75.81

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$21.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?